Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.95 (-0.25) | AIM:£2.29 (-0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 6 Jun 2012

Hutchison MediPharma Limited Announces Presentations of Sulfatinib and Fruquintinib Clinical Data at the 2012 ASCO Annual Meeting